CASP9

Gene Information
 
Gene Symbol
CASP9
 
Aliases
APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56
 
Entrez Gene ID
842
 
Gene Name
Caspase 9
 
Chromosomal Location
1p36.21
 
HGNC ID
 
Summary
This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This protein can undergo autoproteolytic processing and activation by the apoptosome, a protein complex of cytochrome c and the apoptotic peptidase activating factor 1; this step is thought to be one of the earliest in the caspase activation cascade. This protein is thought to play a central role in apoptosis and to be a tumor suppressor. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2013]
 
RefSeq DNA
 
RefSeq mRNA
  e!Ensembl
Gene
Transcript  
Protein

Gene Ontology (GO)

GO ID Ontology Function Evidence Reference
GO:0006915 Biological process Apoptotic process IBA 21873635
GO:0006915 Biological process Apoptotic process IMP 15069058
GO:0006915 Biological process Apoptotic process TAS 8663294
GO:0006974 Biological process Cellular response to DNA damage stimulus IDA 15657060
GO:0008630 Biological process Intrinsic apoptotic signaling pathway in response to DNA damage IBA 21873635
Protein Information
 
Protein Name
Caspase-9, ICE-like apoptotic protease 6, apoptotic protease MCH-6, apoptotic protease activating factor 3, caspase 9, apoptosis-related cysteine peptidase, protein phosphatase 1, regulatory subunit 56
 
Function
Involved in the activation cascade of caspases responsible for apoptosis execution. Binding of caspase-9 to Apaf-1 leads to activation of the protease which then cleaves and activates caspase-3. Promotes DNA damage-induced apoptosis in a ABL1/c-Abl-dependent manner. Proteolytically cleaves poly(ADP-ribose) polymerase (PARP).; Isoform 2 lacks activity is an dominant-negative inhibitor of caspase-9
 
Refseq Proteins
 
UniProt
 
PDB
Pathways
 
KEGG
 
Reactome
 

Platinum drug resistance
p53 signaling pathway
PI3K-Akt signaling pathway
Apoptosis
Apoptosis - multiple species
VEGF signaling pathway
Thyroid hormone signaling pathway
Alzheimer disease
Parkinson disease
Amyotrophic lateral sclerosis (ALS)
Huntington disease
Legionellosis
Toxoplasmosis
Tuberculosis
Hepatitis C
Hepatitis B
Measles
Human cytomegalovirus infection
Influenza A
Kaposi sarcoma-associated herpesvirus infection
Herpes simplex virus 1 infection
Epstein-Barr virus infection
Human immunodeficiency virus 1 infection
Pathways in cancer
Colorectal cancer
Pancreatic cancer
Endometrial cancer
Prostate cancer
Small cell lung cancer
Non-small cell lung cancer
Viral myocarditis

 

Formation of apoptosome
Activation of caspases through apoptosome-mediated cleavage
NOD1/2 Signaling Pathway
AKT phosphorylates targets in the cytosol
Caspase activation via Dependence Receptors in the absence of ligand
Constitutive Signaling by AKT1 E17K in Cancer
Regulation of the apoptosome activity

Interactions
 
STRING MINT IntAct
ENSP00000265641 P50416 P50416
    View interactions
     

Associated Diseases

Disease groupDisease NameReferences
Digestive System Diseases
Pancreatitis
Endocrine System Diseases
PCOS
Eye Diseases
Retinal Detachment
Retinal Pigment Epithelial Detachment
Neoplasms
Prostate cancer
References
 
 
PubMed ID Associated gene/s Associated condition Genetic Mutation Diagnostic Criteria Association with PCOS Ethnicity Conclusion
Caspase 3, Caspase 7 
PCOS 
 
2003 Rotterdam ESHRE/ASRMcriteria 
Related 
Forty-four women with PCOS and 44 healthy women as controls 
The circulating caspase 9 and oxidant status might contribute to apoptotic dysregulation in PCOS 

| © 2019, Biomedical Informatics Centre, NIRRH |
National Institute for Research in Reproductive Health, Jehangir Merwanji Street, Parel, Mumbai-400 012
Tel: 91-22-24192104, Fax No: 91-22-24139412